Log in

NASDAQ:MMSI - Merit Medical Systems Stock Price, Forecast & News

-2.71 (-8.22 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
Now: $30.27
50-Day Range
MA: $36.12
52-Week Range
Now: $30.27
Volume394,811 shs
Average Volume760,115 shs
Market Capitalization$1.67 billion
P/E Ratio336.37
Dividend YieldN/A
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions. The company also offers cardiovascular and critical care products to treat patients with life-threatening diseases, protect healthcare providers from exposure to bloodborne pathogens, and provide medical devices. In addition, it provides interventional oncology and spine products comprising delivery system, embolotherapy, spine ablation, and vertebral compression fracture products to treat metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, the company offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical system sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Read More
Merit Medical Systems logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:MMSI



Sales & Book Value

Annual Sales$994.85 million
Cash Flow$3.11 per share
Book Value$17.21 per share


Net Income$5.45 million


Market Cap$1.67 billion
Next Earnings Date4/28/2020 (Estimated)

Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

How has Merit Medical Systems' stock been impacted by COVID-19 (Coronavirus)?

Merit Medical Systems' stock was trading at $32.88 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MMSI shares have decreased by 7.9% and is now trading at $30.27. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Merit Medical Systems?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Merit Medical Systems.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Merit Medical Systems.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) released its quarterly earnings data on Monday, February, 24th. The medical instruments supplier reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.06. The medical instruments supplier earned $257.92 million during the quarter, compared to the consensus estimate of $252.31 million. Merit Medical Systems had a net margin of 0.55% and a return on equity of 8.67%. The business's revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.48 EPS. View Merit Medical Systems' earnings history.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems updated its FY20 earnings guidance on Monday, February, 24th. The company provided earnings per share guidance of $1.58-1.68 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.56. The company issued revenue guidance of $1.044-1.064 billion, compared to the consensus revenue estimate of $1.05 billion.

What price target have analysts set for MMSI?

10 Wall Street analysts have issued 1-year price objectives for Merit Medical Systems' stock. Their forecasts range from $30.00 to $74.00. On average, they anticipate Merit Medical Systems' stock price to reach $42.44 in the next twelve months. This suggests a possible upside of 40.2% from the stock's current price. View analysts' price targets for Merit Medical Systems.

What are Wall Street analysts saying about Merit Medical Systems stock?

Here are some recent quotes from research analysts about Merit Medical Systems stock:
  • 1. Barrington Research analysts commented, "We would gently suggest that with shares down over 55% over the past few months that perhaps the miss, the guidedown, the “drama”, and even a riskier near‐term growth profile might mostly be “in the stock” at this point. We simply think the risk/reward now favors investment – even if Q3 comes in soft. We will try to make our argument in brief below." (9/12/2019)
  • 2. According to Zacks Investment Research, "Shares of Merit Medical outperformed the industry in a year’s time. Significant expansion in adjusted gross margins in recent times buoy optimism in the stock. Robust Cardiovascular unit also encourages. Management is optimistic about Merit Medical’s Becton Dickinson deal that is set for completion at the end of 2019. Cianna Medical and Vascular Insights buyouts continue to contribute to results. Management is optimistic about several new products that are slated for introduction in the second quarter of 2019. However, escalating operating expenses remains a concern for the company. Headwinds like stiff competition and higher consolidation in the healthcare industry add to the woes. Sluggishness in the Custom kits and procedure trays and Embolization devices units is also concern. The stock is overvalued at the moment." (7/1/2019)
  • 3. Needham & Company LLC analysts commented, "MMSI’s 1Q19 revenue and EPS beat consensus (due to a lower than expected tax rate). Management reiterated its 2019 revenue and EPS guidance. Organic revenue growth slowed from 4Q18 despite an easier comp. Gross margin expansion was partially offset by higher SG&A but MMSI still delivered 60 bps of Y/Y operating margin improvement. We still believe there are multiple sources of upside to revenue (e.g. BD products are organic, Cianna SCOUT would be incremental) and EPS guidance (e.g. continued margin improvement) and we reiterate our Buy rating." (4/25/2019)

Has Merit Medical Systems been receiving favorable news coverage?

News articles about MMSI stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Merit Medical Systems earned a coverage optimism score of -1.5 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the near future. View the latest news aboutMerit Medical Systems.

Are investors shorting Merit Medical Systems?

Merit Medical Systems saw a drop in short interest in February. As of February 14th, there was short interest totaling 5,650,000 shares, a drop of 19.2% from the January 30th total of 6,990,000 shares. Based on an average daily trading volume, of 782,700 shares, the days-to-cover ratio is currently 7.2 days. Currently, 10.6% of the shares of the stock are sold short. View Merit Medical Systems' Current Options Chain.

Who are some of Merit Medical Systems' key competitors?

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), Exfo (EXFO), RTI Surgical (RTIX), Energy Transfer LP Unit (ET), Under Armour (UA), Johnson & Johnson (JNJ) and Neurometrix (NURO).

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the following people:
  • Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 69)
  • Mr. Ronald A. Frost, Chief Operating Officer (Age 57)
  • Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 58)
  • Mr. Joseph C. Wright, Pres of International Division (Age 49)
  • Mr. Raul Parra Jr., CPA, CFO & Treasurer

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include ArrowMark Colorado Holdings LLC (9.57%), Nuance Investments LLC (3.82%), State Street Corp (3.55%), Conestoga Capital Advisors LLC (3.33%), Macquarie Group Ltd. (3.05%) and Macquarie Group Ltd. (3.05%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, Enterprise Associates 14 New, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost. View institutional ownership trends for Merit Medical Systems.

Which major investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Rothschild & Co. Asset Management US Inc., Public Employees Retirement Association of Colorado, UBS Asset Management Americas Inc., Conestoga Capital Advisors LLC, Credit Suisse AG, Bank of America Corp DE, and Emerald Mutual Fund Advisers Trust. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, and Raul Jr Parra. View insider buying and selling activity for Merit Medical Systems.

Which major investors are buying Merit Medical Systems stock?

MMSI stock was acquired by a variety of institutional investors in the last quarter, including Nuance Investments LLC, ArrowMark Colorado Holdings LLC, William Blair Investment Management LLC, Massachusetts Financial Services Co. MA, Soltis Investment Advisors LLC, Norges Bank, FMR LLC, and Walthausen & Co. LLC. Company insiders that have bought Merit Medical Systems stock in the last two years include Enterprise Associates 14 New, Raul Jr Parra, and Ronald Frost. View insider buying and selling activity for Merit Medical Systems.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $30.27.

How big of a company is Merit Medical Systems?

Merit Medical Systems has a market capitalization of $1.67 billion and generates $994.85 million in revenue each year. The medical instruments supplier earns $5.45 million in net income (profit) each year or $1.46 on an earnings per share basis. Merit Medical Systems employs 6,355 workers across the globe. View additional information about Merit Medical Systems.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is http://www.merit.com/.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]

MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  321 (Thanks for Voting!)
Underperform Votes:  295 (Thanks for Voting!)
Total Votes:  616
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel